StockNews.com began coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research report sent to investors on Saturday morning. The firm issued a hold rating on the stock. TherapeuticsMD Trading Up 1.4 % TXMD stock opened at $2.14 on Friday. TherapeuticsMD has a fifty-two week low of $1.84 and a fifty-two week high […]